KYLE CRAIG: Open Payments
NPI 1841076361 · JACKSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,467 in 120 payments from 13 companies in 2025. Trend: 2023 $92 · 2024 $808 · 2025 $2,467
Food & beverage: $2,375Education: $91
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $468 |
| Otsuka America Pharmaceutical, Inc. | 12 | $367 |
| Axsome Therapeutics, Inc. | 15 | $301 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $276 |
| Teva Pharmaceuticals USA, Inc. | 21 | $248 |
| Alkermes, Inc. | 10 | $219 |
| E.R. Squibb & Sons, L.L.C. | 5 | $200 |
| Janssen Pharmaceuticals, Inc | 3 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $76 |
| Lundbeck LLC | 2 | $62 |
Products named: VRAYLAR, Auvelity, CAPLYTA, REXULTI, ARISTADA, COBENFY, SPRAVATO, ABILIFY ASIMTUFII.
Industry payments across TN — which companies pay providers there.
